EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor: A Randomized Trial

Parneet Grewal iD, Ashley M Wabnitz iD, Jenifer H Voeks, Souvik Sen iD, Tushar Trivedi iD, Carol Joseph, Kenreka T Yeadon, Raelle Tagge, Bruce Ovbiagele iD

Journal of the American Heart Association · 01.09.2026 · 15 (17)

DOI: 10.1161/jaha.125.048147 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 01.09.2026. Verfasst von Parneet Grewal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Medical University of South Carolina Charleston SC USA. Hauptthemen laut MEDLINE: Antihypertensive Agents, Blood Pressure, Hypertension, Medication Adherence. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Individuals residing in the southeastern United States experience disproportionately worse stroke outcomes. Although blood pressure ( BP ) reduction is among the most effective strategies for improving stroke outcomes, fewer than one third of survivors of stroke achieve BP control within 1 year of the index event.

Methods

The PACESETTER (Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor) trial enrolled patients with stroke and uncontrolled BP from 3 safety‐net health care systems in South Carolina. Patients were randomized 1:1 to the PACESETTER intervention, which included a Bluetooth‐enabled electronic pill tray, a BP monitor, and a smartphone application for automated data transmission of medication adherence and BP data to a central server or to usual care. The primary outcome was systolic BP

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsBlood PressureHypertensionMedication AdherenceStrokeAdherence InterventionsAgedFemaleHumansMaleMiddle AgedRisk FactorsSouth Carolina

Stichwörter der Autor:innen

blood pressurecerebrovascular diseasedisparitieshypertensionpreventionstroke

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Neurology Medical University of South Carolina Charleston SC USA.
  • Department of Neurology University of South Carolina Charleston SC USA.
  • College of Medicine, Medical University of South Carolina Charleston SC USA.
  • Northern California Institute for Research and Education San Francisco CA USA.
  • Department of Neurology University of California, San Francisco CA USA.

ORCID-Profile: Parneet Grewal, Ashley M Wabnitz, Souvik Sen, Tushar Trivedi, Bruce Ovbiagele

Zitieren

APA

Grewal, P., Wabnitz, A. M., Voeks, J. H., Sen, S., Trivedi, T., Joseph, C., Yeadon, K. T., Tagge, R., & Ovbiagele, B. (2026). Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor: A Randomized Trial. Journal of the American Heart Association, 15(17). https://doi.org/10.1161/jaha.125.048147

Vancouver

Grewal P, Wabnitz AM, Voeks JH, Sen S, Trivedi T, Joseph C, et al. Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor: A Randomized Trial. Journal of the American Heart Association. 2026;15(17). doi:10.1161/jaha.125.048147

BibTeX
@article{Grewal2026,
  author = {Grewal, Parneet and Wabnitz, Ashley M and Voeks, Jenifer H and Sen, Souvik and Trivedi, Tushar and Joseph, Carol and Yeadon, Kenreka T and Tagge, Raelle and Ovbiagele, Bruce},
  title = {Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk Factor: A Randomized Trial},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {17},
  doi = {10.1161/jaha.125.048147}
}
Kostenlos starten →